This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 May;311(20):2129.

doi: 10.1001/jama.2014.3420.

Trial evidence and approval of therapeutic agents--reply

Nicholas S Downing¹, Joseph S Ross¹

Affiliations

PMID: 24867021
DOI: 10.1001/jama.2014.3420

Comment

Trial evidence and approval of therapeutic agents--reply

Nicholas S Downing et al. JAMA. 2014 May.

. 2014 May;311(20):2129.

doi: 10.1001/jama.2014.3420.

Authors

Nicholas S Downing¹, Joseph S Ross¹

Affiliation

¹ Yale University, New Haven, Connecticut.

PMID: 24867021
DOI: 10.1001/jama.2014.3420

No abstract available

PubMed Disclaimer

Comment on

Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.
Downing NS, Aminawung JA, Shah ND, Krumholz HM, Ross JS. Downing NS, et al. JAMA. 2014 Jan 22-29;311(4):368-77. doi: 10.1001/jama.2013.282034. JAMA. 2014. PMID: 24449315 Free PMC article.
Trial evidence and approval of therapeutic agents.
Green AM, Simon LS. Green AM, et al. JAMA. 2014 May;311(20):2128-9. doi: 10.1001/jama.2014.3401. JAMA. 2014. PMID: 24867019 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations